The Conversation (0)
Avinger (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that the Company will effect a 1-for-40 reverse stock split of the Company’s common stock, which will be effective at 5:00 p.m. Eastern time on Tuesday, January 30, 2018. As quoted in the press release press release: “The reverse stock …
Avinger (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that the Company will effect a 1-for-40 reverse stock split of the Company’s common stock, which will be effective at 5:00 p.m. Eastern time on Tuesday, January 30, 2018.
As quoted in the press release press release:
“The reverse stock split is a critical step in our strategy to maintain the Company’s Nasdaq listing and is an important component of our broader strategy to strengthen the Company’s capital position,” said Jeff Soinski, Avinger’s president and CEO.
